Article

Pancreatic cancer progress illustrated in facts, figures and faces

Author(s):

Elizabeth Whittington

Elizabeth whittington blog image

Pancreatic cancer, while hard to treat, is gaining awareness, research dollars and inspirational advocates. Learn more about how we're gaining on this aggressive cancer in the Winter issue of CURE.You can also view an informational video based on the "Changing Course in Pancreatic Cancer" article below.

Related Videos
Image of smiling doctor.
Related Content
The EC has approved Rytelo in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome: © Crystal_Light - stock.adobe.com.
March 25th 2025

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

Ryan Scott
The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Chester Freeman was diagnosed with bladder cancer and most recently with chronic lymphocytic leukemia (CLL). Read Chester's blogs here!
March 25th 2025

Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia

Chester Freeman
Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of lungs.
March 25th 2025

First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer

Spencer Feldman
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer.
During Colorectal Cancer Awareness Month, Dr. Shyam Thakkar discussed rates of this disease in young adults: © Suttipun - stock.adobe.com.
March 25th 2025

Raising Awareness for Colorectal Cancer, On the Rise in Younger Adults

Alex Biese
During Colorectal Cancer Awareness Month, Dr. Shyam Thakkar discussed rates of this disease in young adults, the role of AI and disparities in care.